These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3811525)

  • 21. Hypercholesterolemia in children.
    Shamir R; Lerner A; Fisher EA
    Isr Med Assoc J; 2000 Oct; 2(10):767-71. PubMed ID: 11344730
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of the atherosclerotic diseases--opportunities for military medicine.
    Froelicher VF; Lancaster MC
    Aerosp Med; 1973 May; 44(5):542-8. PubMed ID: 4541192
    [No Abstract]   [Full Text] [Related]  

  • 23. Dietary factors and serum lipids.
    Mathur KS
    Indian Heart J; 1983; 35(4):250-4. PubMed ID: 6313518
    [No Abstract]   [Full Text] [Related]  

  • 24. [A hypothesis prevails: cholesterol and coronary heart disease].
    Battegay E
    Praxis (Bern 1994); 1998 Oct; 87(43):1425-7. PubMed ID: 9844486
    [No Abstract]   [Full Text] [Related]  

  • 25. The management of hypercholesterolemia revisited.
    Wiggins BS
    Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AHA and ACC outline approaches to coronary disease risk assessment.
    Morey SS
    Am Fam Physician; 2000 Apr; 61(8):2534, 2537-8, 2541-2. PubMed ID: 10794587
    [No Abstract]   [Full Text] [Related]  

  • 27. A clinico-pathological study of coronary heart disease in Ceylon.
    Nimalasuriya A; Wimalaratne KD; Thenabadu PN
    Ceylon Med J; 1971 Jun; 16(2):86-90. PubMed ID: 5163549
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
    Más R; Castaño G; Illnait J; Fernández L; Fernández J; Alemán C; Pontigas V; Lescay M
    Clin Pharmacol Ther; 1999 Apr; 65(4):439-47. PubMed ID: 10223782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of a worksite cholesterol education program over a 5-year period.
    Perovich SJ; Sandoval WM
    J Am Diet Assoc; 1995 May; 95(5):589-90. PubMed ID: 7722197
    [No Abstract]   [Full Text] [Related]  

  • 30. [The indices of coronary risk. Their distribution in a middle-aged male population. Proposed overall index of risk].
    Puddu V; Menotti A
    Cuore Circ; 1966 Dec; 50(6):329-42. PubMed ID: 5997766
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of the high risk patient.
    Taplin NE
    Occup Health Nurs; 1984 Feb; 32(2):67-71. PubMed ID: 6560350
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening for hypercholesterolaemia in patients with other risk factors for coronary heart disease.
    Lee GH; Su DH; Su DH; Fong AC; Chow YH
    Singapore Med J; 1999 Jun; 40(6):397-401. PubMed ID: 10489507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cholesterol, inborn errors of lipid metabolism and ischemic heart disease in the light of epidemiological studies].
    Santrůcek M; Geizerová H; Sobra J
    Cesk Zdrav; 1977 Feb; 25(2):88-93. PubMed ID: 844136
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular complications of familial hypercholesteremic tendinous xanthomatosis (FHTX). Apropos of 400 cases of FHTX (type IIa, with tendinous xanthomas)].
    De Gennes JL; Turpin G; Narboni G; Truffert J
    Ann Med Interne (Paris); 1974 Dec; 125(12):889-902. PubMed ID: 4469952
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women.
    Thomas F; Bean K; Guize L; Quentzel S; Argyriadis P; Benetos A
    Eur Heart J; 2002 Apr; 23(7):528-35. PubMed ID: 11922642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypercholesterolemia in Belgium in 1996: an epidemiological viewpoint].
    Kornitzer M; De Bacquer D; De Backer G
    Rev Med Brux; 1997 Feb; 18(1):16-25. PubMed ID: 9132913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective management of patients with dyslipidemia.
    Lipsy RJ
    Am J Manag Care; 2003 Feb; 9(2 Suppl):S39-58. PubMed ID: 12597240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk factors in coronary disease].
    Schär M
    Schweiz Med Wochenschr; 1972 Nov; 102(47):1702-4. PubMed ID: 4647939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.